OSEMITAMAB
UNII H14V1A2F4D

Substance Identification & Data

This profile provides standardized clinical and technical data for Osemitamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H14V1A2F4D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2460539-61-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H14V1A2F4D

CAS Registry Number

2460539-61-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OSEMITAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C173726

National Cancer Institute reference terminology for clinical and research data.

INN ID

11927

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-140

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Osemitamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OSEMITAMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN CLAUDIN 18.2) (HUMAN-MUS MUSCULUS MONOCLONAL TST001 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL TST001 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CLDN18 (SFTPJ, SURFACTANT ASSOCIATED PROTEIN J) ISOFORM 2, EXTRACELLULAR DOMAIN 1 (EC1)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-448) (VH (HOMO SAPIENS IGHV1-46*01 (87.8%) -(IGHD) -IGHJ4*01 (92.9%) L123>T (113), CDR-IMGT (8.8.11) (26-33.51-58.97-107)) (1-118) -HOMO SAPIENS IGHG1*01 (100%), G1M17,1 (CH1 K120 (215) (119-216), HINGE 1-15 (217-231), CH2 (232-341), CH3 D12 (357), L14 (359) (342-446), CHS (447-448)) (119-448)), (221-220')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-220') (VKAPPA (HOMO SAPIENS IGKV4-1*01 (91.1%) - IGKJ4*01 (100%), CDR-IMGT (12.3.9) (27-38.56-58.95-103)) (1'-113') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (159), V101 (197) (114'-220')); DIMER (227-227'':230-230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1 LACKING THE GLUTAMINE SYNTHETASE (GS-KO) GENE, GLYCOFORM ALFA

OSEMITAMAB [INN]

OSEMITAMAB [USAN]

TST 001 [WHO-DD]